HPV
Phase II Trial of Transgene HPV-Targeted Cancer Vaccine Misses Primary Endpoint
Treatment with the vaccine did not improve progression-free survival in patients with HPV16-positive cervical and anogenital tumors.
TheraVectys Launches Phase I/IIa Trial of HPV-Targeted Vaccine in Cervical, Oropharyngeal Cancers
The trial will include patients with newly diagnosed, treatment-naïve cancers as well as those with recurrent or metastatic disease.
SCG Cell Therapy to Begin Phase I Trial of T-Cell Receptor Therapy in HPV-Associated Solid Tumors
The FDA's clearance of its IND allows the firm to take a second T-cell receptor therapy into clinical trials.
Researchers Highlight Progress in Head and Neck Cancer MRD at ASCO, but Results Remain Preliminary
Premium
Clinicians said that residual disease tests could be of great benefit to this population, but advancing technologies will still have to prove themselves.
The firm's long-term goal is to develop targeted cancer vaccines for patients at every stage of disease, including pre-cancer.
Nov 30, 2023